This study highlights that heterogeneous drug distribution inside tumor tissues can lead to insufficient chemotherapy, thereby accelerating EMT, and promoting tumor metastasis by downregulating E-cadherin and upregulating N-cadherin. The gene discussed is CDH2; the disease is neoplasm.